» Articles » PMID: 36010684

Recent Advances in the Modulation of Pain by the Metabotropic Glutamate Receptors

Overview
Journal Cells
Publisher MDPI
Date 2022 Aug 26
PMID 36010684
Authors
Affiliations
Soon will be listed here.
Abstract

Metabotropic glutamate receptors (mGluR or mGlu) are G-protein coupled receptors activated by the binding of glutamate, the main classical neurotransmitter of the nervous system. Eight different mGluR subtypes (mGluR1-8) have been cloned and are classified in three groups based on their molecular, pharmacological and signaling properties. mGluRs mediate several physiological functions such as neuronal excitability and synaptic plasticity, but they have also been implicated in numerous pathological conditions including pain. The availability of new and more selective allosteric modulators together with the canonical orthosteric ligands and transgenic technologies has led to significant advances in our knowledge about the role of the specific mGluR subtypes in the pathophysiological mechanisms of various diseases. Although development of successful compounds acting on mGluRs for clinical use has been scarce, the subtype-specific-pharmacological manipulation might be a compelling approach for the treatment of several disorders in humans, including pain; this review aims to summarize and update on preclinical evidence for the roles of different mGluRs in the pain system and discusses knowledge gaps regarding mGluR-related sex differences and neuroimmune signaling in pain.

Citing Articles

Anti-metabotropic glutamate receptor 5 coexistent anti-N-methyl-D-aspartate receptor encephalitis: a case report and literature review.

Gu Y, Xuan T, Li P, Zhou J, Wang Z Front Immunol. 2025; 16:1436246.

PMID: 40028323 PMC: 11867952. DOI: 10.3389/fimmu.2025.1436246.


NGF in Neuropathic Pain: Understanding Its Role and Therapeutic Opportunities.

Garcia-Dominguez M Curr Issues Mol Biol. 2025; 47(2).

PMID: 39996814 PMC: 11854882. DOI: 10.3390/cimb47020093.


Astragalin relieves inflammatory pain and negative mood in CFA mice by down-regulating mGluR5 signaling pathway.

Zhang R, Lin J, Wang S, Yang C, Zhou C, Yang Y Sci Rep. 2025; 15(1):5774.

PMID: 39962225 PMC: 11832914. DOI: 10.1038/s41598-025-90279-7.


Discovery of 4-(5-Membered)Heteroarylether-6-methylpicolinamide Negative Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5.

Childress E, Capstick R, Crocker K, Ledyard M, Bender A, Maurer M ACS Med Chem Lett. 2024; 15(12):2210-2219.

PMID: 39691522 PMC: 11647725. DOI: 10.1021/acsmedchemlett.4c00481.


Microparticles Mediate Lipopolysaccharide-induced Inflammation and Chronic Pain in Mouse Model.

Singh A, Khushi , Tiwari V, Kumar A Neuromolecular Med. 2024; 26(1):48.

PMID: 39585502 DOI: 10.1007/s12017-024-08809-x.


References
1.
Kiritoshi T, Neugebauer V . Group II mGluRs modulate baseline and arthritis pain-related synaptic transmission in the rat medial prefrontal cortex. Neuropharmacology. 2015; 95:388-94. PMC: 4466036. DOI: 10.1016/j.neuropharm.2015.04.003. View

2.
Zuena A, Mairesse J, Casolini P, Cinque C, Alema G, Morley-Fletcher S . Prenatal restraint stress generates two distinct behavioral and neurochemical profiles in male and female rats. PLoS One. 2008; 3(5):e2170. PMC: 2366064. DOI: 10.1371/journal.pone.0002170. View

3.
Palazzo E, Romano R, Luongo L, Boccella S, De Gregorio D, Giordano M . MMPIP, an mGluR7-selective negative allosteric modulator, alleviates pain and normalizes affective and cognitive behavior in neuropathic mice. Pain. 2015; 156(6):1060-1073. DOI: 10.1097/j.pain.0000000000000150. View

4.
Vergne-Salle P, Bertin P . Chronic pain and neuroinflammation. Joint Bone Spine. 2021; 88(6):105222. DOI: 10.1016/j.jbspin.2021.105222. View

5.
Ottani A, Leone S, Vergara F, Tacchi R, Loche A, Bertolini A . Preference for palatable food is reduced by the gamma-hydroxybutyrate analogue GET73, in rats. Pharmacol Res. 2007; 55(4):271-9. DOI: 10.1016/j.phrs.2006.12.002. View